ProtoKinetix, Incorporated (ProtoKinetix, Inc.) Aktie
PKTX
Verzögert 0 Min.ProtoKinetix, Inc.
Market Cap
$2,169,354
Über ProtoKinetix, Incorporated (ProtoKinetix, Inc.) Aktie
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.
Unternehmensinformationen
44618 Dalton, United States
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.